Macquarie Group’s LifeMD LFMD Stock Holding History

Macquarie Group’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,429	Closed	-$15	–	2025
2024 Q1	$15	Buy	+1,429	New	+$10.6K	﹤0.01%	1708

Other funds holding LFMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Macquarie Group's LFMD Position: Q2 2024 in Review

Macquarie Group sold out of LifeMD (LFMD) in Q2 2024, closing a stake of 1,429 shares — an estimated $15 sold.

Macquarie Group first reported a position in LFMD in Q1 2024 and held it in 1 quarter. The position peaked at $15 in Q1 2024. 104 funds tracked by Wall St. Rank hold LFMD as of Q2 2024.

Macquarie Group reported no remaining LifeMD position as of Q2 2024 after selling out during the quarter.
Macquarie Group sold 1,429 LifeMD shares in Q2 2024, an estimated $15.
Macquarie Group first reported a position in LifeMD in Q1 2024 and held it in 1 quarter.
Macquarie Group's LifeMD position peaked at $15 in Q1 2024.
104 funds tracked by Wall St. Rank held LifeMD as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.